Urinary Catheter Blockage and Encrustation

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Urinary Catheter Blockage and Encrustation trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (3 shown)

Not Yet RecruitingNot Applicable

NCT06815120

A Novel Ureteric Stent in Kidney Stone Patients and Oncology Patients Compared to a Conventional JJ Stent

Urological stents and catheters often lead to inflammation, causing pain and infection in the urinary tract. Moreover, 80% of stents are associated with pain, n…

Location not specified50 participantsStarted 2025-02-28

Treatment: Experimental ureteric stent with specially shaped side-holes that prevent stagnation points (i.e., areas of low flow that cause particles to settle and E&B), Qualitative interview

UnknownPhase 2

NCT02130518

Efficacy Study of Auriclosene Irrigation Solution on Urinary Catheter Patency

Long-term indwelling urinary catheters are associated with chronic recurrent urinary tract infections and blockage caused by crystalline biofilm accumulation (e…

United States140 participantsStarted 2014-09

Treatment: Auriclosene Irrigation Solution, 0.2%, Auriclosene Vehicle Solution

CompletedPhase 2

NCT01243125

Study to Evaluate NVC-422 for Urinary Catheter Blockage and Encrustation

NVC-422 is a topical, non-antibiotic, fast-acting, broad-spectrum anti-microbial, which exhibits the potential to prevent the growth of urinary pathogens, inclu…

United States67 participantsStarted 2010-11

Treatment: NVC-422, 0.2%, Sterile normal saline, 0.9%